TriStar Centennial
August 13, 2020

The Left Atrial Appendage Closure (LAAC) team is excited to offer this new technology to heart patients at TriStar Centennial.

TriStar Centennial Medical Center's Heart and Vascular Center is the first hospital in Tennessee to use the only FDA-approved device to reduce the risk of stroke in patients with atrial fibrillation (AFib) not caused by a heart valve problem. The implanted Left Atrial Appendage Closure (LAAC) Device is an alternative to the lifelong use of blood thinners.

An estimated six million Americans are affected by AFib - an irregular heartbeat that feels like a quivering heart. Patients with AFib have a five-fold increased risk of stroke due to blood clots that can form in an area of the heart called the left atrial appendage and travel to the brain. The new device closes off the left atrial appendage to keep harmful blood clots from entering the blood stream which may decrease the risk of stroke and, over time, patients may be able to stop taking blood thinners.

"We are excited to be able to offer our AFib patients this option that can reduce the risk of stroke and may lead to fewer long term medications," said Dr. Andrew Goodman, an interventional cardiologist at TriStar Centennial Medical Center's Heart and Vascular Center. "Our hospital is committed to offering the latest technology and treatments so our heart patients have the most up-to-date options for managing any cardiac concern."

The device is permanent and is not seen outside the body. Get more information on our Heart and Vascular Center.